Exhibit 99.1

STRATASYS LTD.

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED

JUNE 30, 2020

(UNAUDITED)


INDEX TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2020

(UNAUDITED)

Item

 

Page

Consolidated Balance Sheets

2

Consolidated Statements of Operations and Comprehensive Income (Loss)

3

Consolidated Statements of Changes in Equity

4

Consolidated Statements of Cash Flows

5

Notes to Condensed Consolidated Interim Financial Statements

6-17

1


STRATASYS LTD.

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

(Unaudited)

Consolidated Balance Sheets

(in thousands, except share data)

 

 

 

 

 

 

 

 

 

 

June 30, 2020

 

December 31, 2019

ASSETS

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

284,742

 

 

$

293,484

 

Short-term Deposits

 

 

28,300

 

 

 

28,300

 

Accounts receivable, net

 

 

102,212

 

 

 

132,558

 

Inventories

 

 

164,588

 

 

 

168,504

 

Prepaid expenses

 

 

7,056

 

 

 

6,567

 

Other current assets

 

 

19,969

 

 

 

29,659

 

Total current assets

 

 

606,867

 

 

 

659,072

 

Non-current assets

 

 

 

 

 

 

 

 

Property, plant and equipment, net

 

 

194,437

 

 

 

189,706

 

Goodwill

 

 

385,636

 

 

 

385,658

 

Other intangible assets, net

 

 

75,638

 

 

 

87,328

 

Operating lease right-of-use assets

 

 

17,738

 

 

 

20,936

 

Other non-current assets

 

 

33,744

 

 

 

38,819

 

Total non-current assets

 

 

707,193

 

 

 

722,447

 

Total assets

 

$

1,314,060

 

 

$

1,381,519

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

Accounts payable

 

$

30,600

 

 

$

35,818

 

Accrued expenses and other current liabilities

 

 

23,743

 

 

 

28,528

 

Accrued compensation and related benefits

 

 

29,548

 

 

 

34,013

 

Deferred revenues

 

 

48,617

 

 

 

52,268

 

Operating lease liabilities - short-term

 

 

8,667

 

 

 

9,292

 

Total current liabilities

 

 

141,175

 

 

 

159,919

 

Non-current liabilities

 

 

 

 

 

 

 

 

Deferred revenues - long-term

 

 

13,489

 

 

 

16,039

 

Operating lease liabilities - long-term

 

 

9,493

 

 

 

12,445

 

Other non-current liabilities

 

 

31,576

 

 

 

35,343

 

Total non-current liabilities

 

 

54,558

 

 

 

63,827

 

Total liabilities

 

$

195,733

 

 

$

223,746

 

Contingencies (see note 11)

 

 

 

 

 

 

 

 

Redeemable non-controlling interests

 

 

572

 

 

 

622

 

Equity

 

 

 

 

 

 

 

 

Ordinary shares, NIS 0.01 nominal value, authorized 180,000 thousands shares; 55,030 thousands shares and 54,441 thousands shares issued and outstanding at June 30, 2020 and December 31, 2019, respectively

 

 

150

 

 

 

148

 

Additional paid-in capital

 

 

2,717,963

 

 

 

2,706,894

 

Accumulated other comprehensive loss

 

 

(8,494

)

 

 

(7,716

)

Accumulated deficit

 

 

(1,591,864

)

 

 

(1,542,175

)

Total equity

 

 

1,117,755

 

 

 

1,157,151

 

 

Total liabilities and equity

 

$

1,314,060

 

 

$

1,381,519

 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

2


STRATASYS LTD.

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

(Unaudited)

Consolidated Statements of Operations and Comprehensive Income (Loss)

 

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

in thousands, except per share data

 

2020

 

2019

 

2020

 

2019

Net sales

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Products

 

$

73,877

 

 

$

110,341

 

 

$

157,049

 

 

$

215,432

 

Services

 

 

43,746

 

 

 

52,822

 

 

 

93,481

 

 

 

103,031

 

 

 

 

117,623

 

 

 

163,163

 

 

 

250,530

 

 

 

318,463

 

Cost of sales

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Products

 

 

39,969

 

 

 

47,095

 

 

 

79,217

 

 

 

91,264

 

Services

 

 

33,918

 

 

 

34,901

 

 

 

67,707

 

 

 

69,575

 

 

 

 

73,887

 

 

 

81,996

 

 

 

146,924

 

 

 

160,839

 

Gross profit

 

 

43,736

 

 

 

81,167

 

 

 

103,606

 

 

 

157,624

 

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development, net

 

 

21,303

 

 

 

24,040

 

 

 

45,497

 

 

 

46,614

 

Selling, general and administrative

 

 

51,711

 

 

 

56,322

 

 

 

107,287

 

 

 

113,476

 

 

 

 

73,014

 

 

 

80,362

 

 

 

152,784

 

 

 

160,090

 

Operating income (loss)

 

 

(29,278

)

 

 

805

 

 

 

(49,178

)

 

 

(2,466

)

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial income (expenses), net

 

 

149

 

 

1,755

 

 

 

(680

)

 

 

2,508

 

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) before income taxes

 

 

(29,129

)

 

 

2,560

 

 

 

(49,858

)

 

 

42

 

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income tax expenses (benefit)

 

 

(2,128

)

 

 

1,280

 

 

 

(1,907

)

 

 

2,498

 

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Share in profits (losses) of associated companies

 

 

(950

)

 

 

(195

)

 

 

(1,788

)

 

 

1,228

 

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

(27,951

)

 

$

1,085

 

 

$

(49,739

)

 

$

(1,228

)

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) attributable to non-controlling interests

 

 

35

 

 

 

(67

)

 

 

(50

)

 

 

(110

)

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) attributable to Stratasys Ltd.

 

$

(27,986

)

 

$

1,152

 

 

$

(49,689

)

 

$

(1,118

)

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net earnings (loss) per ordinary share attributable to Stratasys Ltd. - basic and diluted

 

$

(0.51

)

 

$

0.02

 

 

$

(0.91

)

 

$

(0.02)

 

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average ordinary shares outstanding -

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

54,917

 

 

 

54,231

 

 

 

54,733

 

 

 

54,102

Diluted

 

 

54,917

 

 

 

54,687

 

 

 

54,733

 

 

 

54,102

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Comprehensive income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

 

(27,951

)

 

 

1,085

 

 

 

(49,739

)

 

 

(1,228

)

Other comprehensive income (loss), net of tax:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustments

 

 

287

 

 

(17

)

 

 

(1,667

)

 

 

(444

)

Unrealized gains on derivatives designated as cash flow hedges

 

 

67

 

 

 

155

 

 

 

889

 

 

 

1,150

 

Other comprehensive income (loss), net of tax

 

 

354

 

 

138

 

 

 

(778)

 

 

 

706

 

Comprehensive income (loss)

 

 

(27,597

)

 

 

1,223

 

 

 

(50,517

)

 

 

(522

)

Less: comprehensive income (loss) attributable to non-controlling interests

 

 

35

 

 

(67

)

 

 

(50

)

 

 

(110

)

Comprehensive income (loss) attributable to Stratasys Ltd.

 

$

(27,632

)

 

$

1,290

 

 

$

(50,467

)

 

$

(412

)

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

3


STRATASYS LTD.

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

(Unaudited)

Consolidated Statements of Changes in Equity

(in thousands)

Three and Six Months Ended June 30, 2020 and 2019

Ordinary Shares

Additional

Paid-In

Accumulated

Accumulated

Other

Comprehensive

Total

Equity

Number of

Par

shares

Value

Capital

deficit

Loss

Balance as of December 31, 2019

54,441

148

2,706,894

(1,542,175

)

(7,716

)

1,157,151

 

Issuance of shares in connection with stock-based compensation plans

358

1

29

-

-

30

 

Stock-based compensation

-

-

4,907

-

-

4,907

 

Comprehensive loss

-

-

-

(21,703

)

(1,132

)

(22,835

)

Balance as of March 31, 2020

$

54,799

$

149

$

2,711,830

$

(1,563,878

)

$

(8,848

)

$

1,139,253

Issuance of shares in connection with stock-based compensation plans

231

1

22

-

-

23

 

Stock-based compensation

-

-

6,111

-

-

6,111

 

Comprehensive income (loss)

-

-

-

(27,986

)

354

(27,632

)

Balance as of June 30, 2020

$

55,030

$

150

$

2,717,963

$

(1,591,864

)

$

(8,494

)

$

1,117,755

 

Ordinary Shares

Additional

Paid-In

Accumulated

Accumulated

Other

Comprehensive

Total

Equity

Number of

Par

shares

Value

Capital

deficit

Loss

Balance as of December 31, 2018

53,881

 

146

2,681,048

(1,531,326

)

 

(7,753

)

 

1,142,115

 

Cumulative effect of changes in accounting principles

-

-

-

-

-

-

Issuance of shares in connection with stock-based compensation plans

167

*

2,222

-

-

2,222

 

Stock-based compensation

-

-

4,229

-

-

4,229

 

Comprehensive income (loss)

-

 

-

 

-

 

(2,270

)

568

 

(1,702

)

Balance asof March 31, 2019

54,048

 

$

146

 

$

2,687,499

 

$

(1,533,596

)

$

(7,185

)

$

1,146,864

 

 

Issuance of shares in connection with stock-based compensation plans

296

1

2,030

-

-

2,031

 

Stock-based compensation

-

-

6,093

-

-

6,093

 

Comprehensive income

-

 

-

 

-

 

1,152

 

138

 

1,290

 

Balance as ofJune 30, 2019

54,344

 

$

147

 

$

2,695,622

 

$

(1,532,444

)

$

(7,047

)

$

1,156,278

 

* Represents an amount less than 0.5 thousand

 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

4


STRATASYS LTD.

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

(Unaudited)

Consolidated Statements of Cash Flows

Six Months Ended June 30,

in thousands

2020

2019

Cash flows from operating activities

Net loss

$

(49,739

)

$

(1,228

)

Adjustments to reconcile net loss to net cash provided by operating activities:

Depreciation and amortization

25,104

25,063

Stock-based compensation

11,018

10,322

Foreign currency transaction loss (gain)

1,006

(1,603

)

Deferred income taxes

(26

)

(1,123

)

Gain from sale of unconsolidated entity

-

(3,578

)

Share in losses (profits) of associated companies

1,788

(1,228

)

Other non-cash items, net

385

903

Change in cash attributable to changes in operating assets and liabilities:

Accounts receivable, net

29,858

6,372

Inventories

2,382

(27,128

)

Net investment in sales-type leases

679

1,801

Other current assets and prepaid expenses

5,512

(6,390

)

Other non-current assets

3,046

3,875

Accounts payable

(8,684

)

8,812

Other current liabilities

(7,992

)

(12,798

)

Deferred revenues

(6,092

)

(1,357

)

Other non-current liabilities

(6,723

)

122

Net cash provided by operating activities

1,522

837

Cash flows from investing activities

Purchase of property and equipment

(13,030

)

(10,423

)

Proceeds from sale of equity method investment

3,175

-

Net proceeds from divestitures of subsidiaries and associated companies

1,000

-

Proceeds from sale of plant and property

-

129

Purchase of intangible assets

(726

)

(800

)

Proceeds from sale of subsidiaries and unconsolidated entity

-

4,909

Other investing activities

144

(385

)

Net cash used in investing activities

(9,437

)

(6,570

)

Cash flows from financing activities

Repayment of debt

-

(27,293

)

Proceeds from exercise of stock options

53

4,252

Net cash provided by (used in) financing activities

53

(23,041

)

Effect of exchange rate changes on cash, cash equivalents and restricted cash

(880

)

1,697

Net change in cash, cash equivalents and restricted cash

(8,742

)

(27,077

)

Cash, cash equivalents and restricted cash, beginning of period

293,597

393,734

Cash, cash equivalents and restricted cash, end of period

$

284,855

$

366,657

Supplemental disclosures of cash flow information:

Transfer of inventory to fixed assets

1,327

2,614

Transfer of fixed assets to inventory

21

127

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

5


STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

Note 1. Business Description and Basis of Presentation

Stratasys Ltd. (collectively with its subsidiaries, the “Company”) is a global provider of applied additive technology solutions for a broad range of industries. The Company focuses on customers’ business requirements and seeks to create new value for its customers across their product lifecycle processes, from design prototypes to manufacturing tools and final production parts. The Company operates a 3D printing ecosystem of solutions and expertise, comprised of: 3D printers ranging from entry-level desktop 3D printers to systems for rapid prototyping (“RP”) and large production systems for direct digital manufacturing (“DDM”) based on precise fused deposition modeling (“FDM”) and PolyJet technologies; advanced materials for use with its 3D printers; software with voxel level control; application-based services; on-demand parts; and key partnerships.

The condensed consolidated interim financial information herein is unaudited; however, such information reflects all adjustments (consisting of normal, recurring adjustments), which are, in the opinion of management, necessary for a fair statement of results for the interim period. The condensed consolidated interim financial statements include the accounts of Stratasys Ltd. and its subsidiaries. All intercompany accounts and transactions, including profits from intercompany sales not yet realized outside the Company, have been eliminated in consolidation.

The Company financial statements are prepared in conformity with U.S. generally accepted accounting principles ("GAAP"), which requires the Company to make estimates based on assumptions about current and, for some estimates, future economic and market conditions which affect reported amounts and related disclosures in its financial statements. Although the Company current estimates contemplate current and expected future conditions, as applicable, it is reasonably possible that actual conditions could differ from the Company expectations, which could materially affect its results of operations and financial position.

In particular, a number of estimates have been and will continue to be affected by the ongoing Coronavirus Disease 2019 (COVID-19) pandemic. The severity, magnitude and duration, as well as the economic consequences of the COVID-19 pandemic, are uncertain, rapidly changing and difficult to predict. As a result, the accounting estimates and assumptions may change over time in response to COVID-19. Such changes could impact the Company’s goodwill, long-lived asset and intangible asset valuation; inventory valuation; assessment of the annual effective tax rate; and the allowance for expected credit losses and bad debt.

The results of operations for the three and six months ended June 30, 2020 are not necessarily indicative of the results to be expected for the full year. Certain financial information and footnote disclosures normally included in the annual consolidated financial statements prepared in accordance with GAAP have been condensed or omitted. The reader is referred to the audited consolidated financial statements and notes thereto for the year ended December 31, 2019, filed with the U.S. Securities and Exchange Commission (the “SEC”) as part of the Company’s Annual Report on Form 20-F for such year on February 26, 2020.

Note 2. New Accounting Pronouncements

Accounting Pronouncements Adopted in the Current Period

In August 2018, the Financial Accounting Standards Board (the “FASB”) issued an Accounting Standards Update (an “ASU”) that clarifies the accounting for implementation costs in cloud computing arrangements. This ASU requires the implementation costs incurred by customers in cloud computing arrangements to be deferred and recognized over the term of the arrangement, if those costs would be capitalized by the customers in a software licensing arrangement. The Company adopted this guidance effective January 1, 2020, with no material impact on its consolidated financial statements.

In June 2016, the FASB issued an ASU that supersedes the existing impairment model for most financial assets to a current expected credit loss model. The new guidance requires an entity to recognize an impairment allowance equal to its current estimate of all contractual cash flows the entity does not expect to collect. The ASU also requires that credit losses relating to available-for-sale debt securities will be recorded through an allowance for credit losses. The Company adopted this guidance effective January 1, 2020, with no material impact on its consolidated financial statements.

6


STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

Recently Issued Accounting Pronouncements Not Yet Adopted

In December 2019, the FASB issued new guidance to simplify the accounting for income taxes by removing certain exceptions to the general principles and simplification of areas such as franchise taxes, step-up in tax basis goodwill, separate entity financial statements and interim recognition of enactment of tax laws or rate changes The guidance will be effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020, with early adoption permitted. The Company is currently evaluating the impact of the adoption of the new guidance on its consolidated financial statements.

7


STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

(UNAUDITED)

Note 3. Revenues

Disaggregation of Revenues

The following table presents the Company’s revenues disaggregated by geographical region (based on the Company's customers' locations) and revenue type for the three and six months ended June 30, 2020 and 2019:

Three months ended June 30,

Six months ended June 30,

2020

2019

2020

2019

(U.S. $ in thousands)

(U.S. $ in thousands)

Americas

Products

$

44,800

$

67,137

$

93,044

$

125,191

Service

33,901

 

40,888

72,230

 

79,332

Total Americas

78,701

 

108,025

165,274

 

204,523

 

EMEA

Products

15,743

23,323

36,490

51,408

Service

5,172

 

6,826

11,345

 

13,524

Total EMEA

20,915

 

30,149

47,835

 

64,932

 

Asia Pacific

Products

13,334

19,881

27,515

38,833

Service

4,673

 

5,108

9,906

 

10,175

Total Asia Pacific

18,007

 

24,989

37,421

 

49,008

 

 

 

Total Revenues

$

117,623

$

163,163

$

250,530

$

318,463

The following table presents the Company’s revenues disaggregated based on the timing of revenue recognition (at a specific point in time or over the course of time) for the three and six months ended June 30, 2020 and 2019:

Three months ended June 30,

Six months ended June 30,

2020

2019

2020

2019

(U.S. $ in thousands)

(U.S. $ in thousands)

Revenues recognized in point in time from:

Products

$

73,877

$

110,341

$

157,049

$

215,432

Services

8,778

 

10,747

19,422

 

21,374

Total revenues recognized in point in time

82,655

 

121,088

176,471

 

236,806

 

Revenues recognized over time from:

Services

34,968

 

42,075

74,059

 

81,657

Total revenues recognized over time

34,968

 

42,075

74,059

 

81,657

 

Total Revenues

$

117,623

$

163,163

$

250,530

$

318,463

8


STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

Contract Assets and Contract Liabilities

Contract assets are recorded when the Company's right to consideration is conditional on constraints other than the passage of time. The Company had no material contract assets as of June 30, 2020 and December 31, 2019.

Contract liabilities include advance payments and billings in excess of revenue recognized, which are primarily related to advanced billings for service type warranty. Contract liabilities are presented under deferred revenues. The Company's deferred revenues as of June 30, 2020 and December 31, 2019 were as follows:

 

June 30,

2020

 

December 31,

2019

 

U.S. $ in thousands

Deferred revenues*

62,106

 

68,307

*Includes $13.5 million and $16.0 million under long term deferred revenue in the Company's consolidated balance sheets as of June 30, 2020 and December 31, 2019, respectively.

Revenue recognized in 2020 that was included in deferred revenue balance as of January 1, 2020 was $13.6 million and $31.6 million for the three and six months ended June 30, 2020, respectively.

Remaining Performance Obligations

Remaining Performance Obligations ("RPO") represents contracted revenue that has not yet been recognized, which includes deferred revenue and amounts that will be invoiced and recognized as revenue in future periods. As of June 30, 2020, the total RPO amounted to $84.0 million. The Company expects to recognize $66.8 million of this RPO during the next 12 months, $12.0 million over the subsequent 12 months and the remaining $5.2 million thereafter.

Incremental Costs of Obtaining a Contract

Sales commissions earned mainly by the Company’s sales agents are considered incremental costs of obtaining a contract with a customer, as the Company expects the benefit of those commissions to be longer than one year. The majority of the sales commissions are not subject to capitalization, as the commission expense is recognized as the related revenue is recognized. Sales commissions for initial contracts related to the service type warranty are deferred and then amortized on a straight-line basis over the expected customer relationship period if the Company expects to recover those costs. Amortization expense is included in selling, general and administrative expenses in the consolidated statements of operations. As of June 30, 2020 and December 31, 2019, the deferred commission amounted to $4.0 million and $3.9 million respectively.

9


STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

Note 4. Inventories

Inventories consisted of the following:

June 30,

2020

December 31,

2019

U.S. $ in thousands

Finished goods

$

84,616

$

87,967

Work-in-process

2,982

3,106

Raw materials

 

76,990

 

77,431

 

 

164,588

 

168,504

Note 5. Goodwill and Other Intangible Assets

Goodwill

Changes in the carrying amount of the Company’s goodwill for the six months ended June 30, 2020 were as follows:

U.S. $ in thousands

Goodwill as of January 1, 2020

$

385,658

Foreign currency translation adjustments

(22

)

Goodwill as of June 30, 2020

$

385,636

 

During the fourth quarter of 2019, the Company performed a quantitative assessment for goodwill impairment for its Stratasys-Objet reporting unit.

Following its quantitative assessment, the Company concluded that the fair value of its Stratasys-Objet reporting unit exceeded its carrying amount by approximately 8.7%, with a carrying amount of goodwill assigned to this reporting unit in an amount of $386 million.

When evaluating the fair value of its Stratasys-Objet reporting unit, the Company used a discounted cash flow model which utilized Level 3 measures that represent unobservable inputs into the valuation method. Key assumptions used to determine the estimated fair value include: (a) expected cash flows for five years following the assessment date which were based on, among other factors, expected revenue growth, costs to produce, operating profit margins and estimated capital needs; (b) an estimated terminal value that utilized a terminal year growth rate of 3.1% that was determined based on the growth prospects of the reporting unit; and (c) a discount rate of 13.5% based on management’s best estimate of the after-tax weighted average cost of capital. If any of these were to vary materially from the Company's estimates, the Company could face impairment of goodwill allocated to this reporting unit in the future.

Actual results may differ from those assumed in the Company's valuation method. It is reasonably possible that the Company's assumptions described above could change in future periods. If any of these were to vary materially from the Company's plans, it may record impairment of goodwill allocated to this reporting unit in the future.

A hypothetical decrease in the growth rate of 1% or an increase of 1% to the discount rate would have reduced the fair value of Stratasys-Objet reporting unit by approximately $45 million and $81 million, respectively.

Based on the Company’s assessment as of December 31, 2019, no goodwill was determined to be impaired.

10


STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

During the first quarter of 2020, the Company performed an analysis of the impact of recent events, including business and industry specific considerations, on the fair value of Stratasys-Objet reporting unit. As part of this analysis the Company considered the potential impacts of COVID-19 and the sensitivity of estimates and assumptions used in the last annual impairment test as well as changes in market capitalization.

During the second quarter of 2020, the Company announced a restructuring plan to reduce operating expenses as part of a cost realignment program to focus on profitable growth (the "Plan"). The Plan’s cost-cutting measures included workforce reductions affecting approximately 10% of employees, as well as other cost-mitigation measures. Please refer to Note 12 for further discussion. The Company reassessed its analysis from the first quarter in light of macroeconomic developments and its cost-cutting measures.

While the goodwill of the reporting unit is not currently impaired, there can be no assurances that goodwill will not be impaired in future periods. The Company will continue to monitor the impact of COVID-19 as well as events and changes in circumstances such as a deterioration in the business climate or operating results, significant decline in the Company's share price, changes in management’s business strategy or downward changes to the Company's cash flows projections.

Other Intangible Assets

Other intangible assets consisted of the following:

June 30, 2020

December 31, 2019

Carrying Amount,

Net of

Impairment

Accumulated

Amortization

Net

Book

Value

Carrying Amount,

Net of

Impairment

Accumulated

Amortization

Net

Book

Value

U.S. $ in thousands

Developed

technology

$

294,105

$

(254,881

)

$

39,224

$

299,100

$

(252,136

)

$

46,964

Patents

15,839

(7,768

)

8,071

15,142

(7,067

)

8,075

Trademarks and trade names

26,004

(20,544

)

5,460

25,991

(19,966

)

6,025

Customer

relationships

101,589

(78,706

)

22,883

102,936

(76,813

)

26,123

Capitalized software

development costs

18,489

(18,489

)

-

18,630

(18,489

)

141

 

$

456,026

$

(380,388

)

$

75,638

$

461,799

$

(374,471

)

$

87,328

Amortization expenses relating to intangible assets for the three-month periods ended June 30, 2020 and 2019 were approximately $6.2 million and $6.0 million, respectively. Amortization expenses relating to intangible assets for the six-month periods ended June 30, 2020 and 2019 were approximately $12.4 million and $12.1 million, respectively.

As of June 30, 2020, the estimated amortization expenses relating to intangible assets for each of the following periods were as follows:

Estimated

amortization expense

(U.S. $ in thousands)

Remaining 6 months of 2020

$

12,421

2021

24,734

2022

24,668

2023

7,732

Thereafter

6,083

Total

75,638

11


STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

Note 6. Earnings (Loss) Per Share

The following table presents the numerator and denominator of the basic and diluted net earnings (loss) per share computations for the three and six months ended June 30, 2020 and 2019:

Three months ended June 30,

Six months ended June 30,

2020

2019

2020

2019

In thousands, except per share amounts

In thousands, except per share amounts

Numerator:

Net income (loss) attributable to Stratasys Ltd.

$

(27,986

)

$

1,152

$

(49,689

)

$

(1,118

)

Denominator:

Weighted average shares - denominator for

Basic

54,917

54,231

54,733

54,102

Diluted

54,917

54,687

54,733

54,102

Net earnings (loss) per share attributable to  Stratasys Ltd.

Basic

$

(0.51

)

$

0.02

$

(0.91

)

$

(0.02

)

Diluted

$

(0.51

)

$

0.02

$

(0.91

)

$

(0.02

)

The computation of diluted net loss per share excluded share awards of 4.9 million shares and 5.1 million shares for the six months ended June 30, 2020 and 2019, respectively, because their inclusion would have had an anti-dilutive effect on the diluted net loss per share.

The computation of diluted net earnings (loss) per share excluded share awards of 4.9 million shares and 3.5 million shares for the three months ended June 30, 2020 and 2019, respectively, because their inclusion would have had an anti-dilutive effect on the diluted net earnings (loss) per share.

Note 7. Income Taxes

The Company had income tax benefit of $2.1 million for the three-month period ended June 30, 2020 compared to income tax expenses of $1.3 million for the three month period ended June 30, 2019, and income tax benefit of $1.9 million for the six-month period ended June 30, 2020 compared to income tax expenses of $2.5 million for the six-month period ended June 30, 2019. The Company’s effective tax rate as of June 30, 2020 was primarily impacted by higher discrete tax benefits following expiration of applicable tax statute of limitations as well as geographic mix of its earnings and losses.

12


STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

Note 8. Fair Value Measurements

Financial instruments measured at fair value

The following tables summarize the Company’s financial assets and liabilities that are carried at fair value on a recurring basis, in its consolidated balance sheets:

June 30, 2020

December 31, 2019

(U.S. $ in thousands)

Assets:

Foreign exchange forward contracts not designated as hedging instruments

$

207

$

63

Foreign exchange forward contracts designated as hedging instruments

479

315

 

Liabilities:

Foreign exchange forward contracts not designated as hedging instruments

(162

)

(388

)

Foreign exchange forward contracts designated as hedging instruments

 

(19

)

 

(326

)

$

505

 

$

(336

)

The Company’s foreign exchange forward contracts are classified as Level 2, as they are not actively traded and are valued using pricing models that use observable market inputs, including interest rate curves and both forward and spot prices for currencies (Level 2 inputs).

Other financial instruments consist mainly of cash and cash equivalents, current and non-current receivables, net investment in sales-type leases, accounts payable and other current liabilities. The fair value of these financial instruments approximates their carrying values.

13


STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

Note 9. Derivative instruments and hedging activities

Since the Company conducts its operations globally, it is exposed to global market risks and to the risk that its earnings, cash flows and equity could be adversely impacted by fluctuations in foreign currency exchange rates. The Company enters into transactions involving foreign currency exchange derivative financial instruments. The Company manages its foreign currency exposures on a consolidated basis, which allows the Company to net exposures and take advantage of any natural hedging. The transactions are designed to manage the Company’s net exposure to foreign currency exchange rates and to reduce the volatility of earnings and cash flows associated with changes in foreign currency exchange rates. The Company does not enter into derivative transactions for trading purposes.

The Company is primarily exposed to foreign exchange risk with respect to recognized assets and liabilities and forecasted transactions denominated in the New Israeli Shekel (“NIS”), Euro, Korean Won, Chinese Yuan and the Japanese Yen. The gains and losses on the hedging instruments partially offset losses and gains on the hedged items. Financial markets and currency volatility may limit the Company’s ability to hedge these exposures. These contracts mature through April 2021.

The following table summarizes the consolidated balance sheets classification and fair values of the Company’s derivative instruments:

Fair Value

Notional Amount

Balance sheet location

June 30,

2020

December 31,

2019

June 30,

2020

December 31,

2019

U.S. $ in thousands

Assets derivatives - Foreign exchange contracts, not designated as hedging instruments

Other current assets

$

207

$

63

$

62,627

$

11,001

Assets derivatives-Foreign exchange contracts, designated as cash flow hedge

Other current assets

479

315

49,980

25,045

Liability derivatives -Foreign exchange contracts, not designated as hedging instruments

Accrued expenses and other current liabilities

(162

)

(388

)

29,348

92,929

Liability derivatives - Foreign exchange contracts, designated as hedging instruments

Accrued expenses and other current liabilities

(19

)

(326

)

9,555

45,262

$

505

$

(336

)

$

151,510

$

174,237

Foreign exchange contracts not designated as hedging instruments

As of June 30, 2020, the notional amounts of the Company’s outstanding exchange forward contracts, not designated as hedging instruments, were $92.0 million, and were used to reduce foreign currency exposures. With respect to such derivatives, losses of $1.1 million and $0.04 million were recognized under financial income (expense), net for the three-month periods ended June 30, 2020 and 2019, respectively and gains of $0.9 million and $1.2 million were recognized under financial income (expense), net for the six-month periods ended June 30, 2020 and 2019, respectively. Such gains or losses partially offset the foreign currencies revaluation changes of the balance sheet items. These foreign currencies revaluation changes are also recognized under financial income (expense), net.

Cash Flow Hedging—Hedges of Forecasted Foreign Currency Payroll

As of June 30, 2020, the Company had in effect foreign exchange forward contracts, designated as cash flow hedge for accounting purposes, for the conversion of $25.5 million into NIS. The Company uses short-term cash flow hedge contracts to reduce its exposure to variability in expected future cash flows resulting mainly from payroll costs denominated in NIS. The changes in fair value of those contracts are included in the Company’s accumulated other comprehensive loss.

14


STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

Cash Flow Hedging—Hedges of Forecasted Foreign Currency Revenue

As of June 30, 2020, the Company had in effect foreign exchange forward contracts, designated as cash flow hedges for accounting purposes, for the conversion of 30.0 million Euro into U.S. dollars. The Company transacts business in U.S. dollars and in various other currencies. The Company may use foreign exchange or forward contracts to hedge certain cash flow exposures resulting from changes in these foreign currency exchange rates. These foreign exchange contracts, carried at fair value, have maturities of up to twelve months. The Company enters into these foreign exchange contracts to hedge a portion of its forecasted foreign currency denominated revenue in the normal course of business and accordingly, they are not speculative in nature.

Note 10. Equity

a. Stock-based compensation plans

Stock-based compensation expenses for equity-classified stock options, restricted share units (“RSUs”) and performance stock units ("PSUs") were allocated as follows:

Three Months Ended

June 30,

Six Months Ended

June 30,

2020

2019

2020

2019

U.S $ in thousands

U.S $ in thousands

Cost of sales

$

497

$

541

$

900

$

895

Research and development, net

1,702

1,511

3,259

2,270

Selling, general and administrative

 

3,912

 

4,041

 

6,859

 

7,157

Total stock-based compensation expenses

$

6,111

$

6,093

$

11,018

$

10,322

A summary of the Company’s stock option activity for the six months ended June 30, 2020 is as follows:

Number of Options

Weighted Average

Exercise Price

Options outstanding as of January 1, 2020

1,961,532

$

31.16

Granted

360,000

17.10

Exercised

(2,237

)

8.09

Forfeited

(76,753

)

28.74

Options outstanding as of June 30, 2020

2,242,542

$

29.01

Options exercisable as of June 30, 2020

1,732,704

$

32.24

As of June 30, 2020, the unrecognized compensation cost of $2.96 million related to all unvested, equity-classified stock options is expected to be recognized as an expense over a weighted-average period of 3.1 years.

15


STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

A summary of the Company’s RSUs and PSUs activity for the six months ended June 30, 2020 is as follows:

Number of RSUs and PSUs

Weighted Average Grant

Date Fair Value

Unvested as of January 1, 2020

 

 

2,362,991

 

 

$

24.10

Granted

1,189,436

18.17

Vested

(587,225

)

23.57

Forfeited

(286,091

)

22.45

Unvested as of June 30, 2020

2,679,111

$

21.76

The fair value of RSUs and PSUs is determined based on the quoted price of the Company’s ordinary shares on the date of the grant.

As of June 30, 2020, the unrecognized compensation cost of $48.8 million related to all unvested, equity-classified RSUs and PSUs is expected to be recognized as expense over a weighted-average period of 2.8 years.

b. Accumulated other comprehensive loss

The following tables present the changes in the components of accumulated other comprehensive income (loss), net of taxes, for the six months ended June 30, 2020 and 2019, respectively:

 

 

Six months ended June 30, 2020

 

 

 

Net unrealized

gain (loss)

on cash

flow hedges

 

Foreign

currency

translation

adjustments

 

Total

 

 

 

U.S. $ in thousands

 

Balance as of January 1, 2020

 

$

(10

)

 

$

(7,706

)

 

$

(7,716

)

Other comprehensive income (loss) before reclassifications

 

 

856

 

 

 

(1,667

)

 

 

(811

)

Amounts reclassified from accumulated other comprehensive loss

 

 

33

 

 

-

 

 

 

33

Other comprehensive income (loss)

 

 

889

 

 

 

(1,667

)

 

 

(778

)

Balance as of June 30, 2020

 

$

879

 

 

$

(9,373

)

 

$

(8,494

)

16


STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

Six months ended June 30, 2019

Net unrealized

gain (loss)

on cash

flow hedges

Foreign

currency

translation

adjustments

Total

U.S. $ in thousands

Balance as of January 1, 2019

$

(627

)

$

(7,126

)

$

(7,753

)

 

Other comprehensive income (loss) before reclassifications

 

1,277

(444

)

833

Amounts reclassified from accumulated other comprehensive loss

 

(127

)

 

-

 

 

(127

)

Other comprehensive income (loss)

 

1,150

 

 

(444

)

 

706

 

Balance as of June 30, 2019

$

523

 

$

(7,570

)

$

(7,047

)

Note 11. Contingencies

Legal proceedings

The Company is a party to various legal proceedings from time to time, the outcome of which, in the opinion of management, will not have a significant effect on the financial position, profitability or cash flows of the Company.

 

Note 12. Restructuring Plan

On June 2, 2020, the Company announced a restructuring plan to reduce operating expenses as part of a cost realignment program to focus on profitable growth (the "Plan"). The Plan’s cost-cutting measures included workforce reductions affecting approximately 10% of employees, as well as other cost-mitigation measures.

The Company recorded $5.2 million and $3.6 million of employee related charges and other related charges, respectively, during the second quarter of 2020. With regards to the employee related charges, $0.6 million was paid during the current period and the rest are expected to be paid during the third quarter. The Company expects to incur additional restructuring charges of approximately $0.5 million, as part of this Plan.

 

17